CMOs Gear Up for Biologics Manufacturing Challenges
Antibody drug conjugate manufacturing | ADC manufacturing process | Challenges & Solutions for safe processing | Closed & automated end-to-end processes | Single Use Support
Biologics Manufacturing Korea 2024 unites industry pioneers, thought leaders, and innovators to delve into the latest trends, challenges, and breakthroughs in biopharmaceutical manufacturing. From August 13 to 15, 2024, BMK serves as a dynamic platform for networking, knowledge exchange, and collaboration...
The Challenges of Virus and Viral Vector Manufacturing One of the key differences between viral products and conventional biologics is the need to infect cells and have multiple rounds of replication to produce the active component. Viral tropism – viruses will only infect certain types o...
ASTaseptic filling productsaddress the unique processing requirements of biologics manufacturing to gently care for biologic products during the fill-finish process. Our highly accurate peristaltic dosing system uses single-use pharmaceutical grade tubing that has been optimized to keep shear stress to an...
Biologics manufacturing challenges can emerge in multiple areas, but leading bio-manufacturers are addressing these difficulties with the help of process intensification (PI). Process intensification refers to a list of comprehensive initiatives that can maximize the efficiency of a bioprocess and make a...
Tara Dougal, Head of Content and Insights at CPhI Worldwide, added:“this year’s agenda will explore many of these issues,and we haveone session, produced in collaboration with BioProduction, which looks specificallyat theviability and commercial challenges of manufa...
Pharmaceutical manufacturers produce drugs derived from chemicals, while biopharmaceutical manufacturers produce drugs derived from life forms (biologics). Both have a major impact on the quality of human life, and so factors such as pin-point accuracy, tight control, safety and consistency are crucial...
Greater Than the Sum of Its Parts: The Cellares Cell Shuttle Living Drugs for Immunotherapy (PDA/FDA Joint Regulatory Conference 2023) Podcasts Podcast: Alternative Drug Delivery Methods for Biologics: Where Are We At? Insights on Purity and Intactness of AAV Gene Therapy Vectors ...
2024年9月10日-11日,澳斯康生物制药将出席参加于新加坡举办的Biologics Contract Manufacturing Asia 2024国际会议,该会专注于生物制药CMO,是亚太地区最受关注的生物制药大会,预计将有300+专业参会者,120+机构,40+专家发言。 澳斯康生物集团董事长兼总裁罗顺博士将在大会进行2场专场演讲和1场圆桌讨论,与到场的国际嘉...